Nutraceuticals and regulation of adipocyte life: Premises or promises

BioFactors

Volumn 40, Issue 4, 2014, Pages 398-418

  Colitti, Monica ^a   Grasso, Stefano ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Adipocytes; Adipogenesis; Apoptosis; Molecular pathways; Nutraceuticals; Obesity

Indexed keywords

CAFFEINE; FUCOXANTHIN; MICRORNA; NATURAL PRODUCT; NUTRACEUTICAL; OLIVE OIL; OMEGA 3 FATTY ACID; RESVERATROL; ANTIOBESITY AGENT;

ADIPOCYTE; ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CELL CYCLE; CURCUMA LONGA; HUMAN; IN VITRO STUDY; METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHODIOLA ROSEA; ROSEMARY; SALACIA; SALACIA RETICULATE; SILYBUM MARIANUM; SOUR ORANGE; TARAXACUM OFFICINALE; WHITE ADIPOSE TISSUE; ADIPOGENESIS; ANIMAL; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECTS; ENERGY METABOLISM; LIPOLYSIS; OBESITY; PHYSIOLOGY;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; CELL CYCLE; DIETARY SUPPLEMENTS; ENERGY METABOLISM; HUMANS; LIPOLYSIS; OBESITY;

EID: 84906790601     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1164     Document Type: Review

References (217)

1. Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., and Zwahen, M. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-578.
2. Hill, J. O. (2006) Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27, 750-761.
3. World Cancer Research Fund/American Institute for Cancer Research. (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. AICR, Washington DC.
4. Min, J., Chiu, D. T., and Wang, Y. (2013) Variation in the heritability of body mass index based on diverse twin studies: a systematic review. Obes. Rev. 14, 871-882.
5. Bell, C. G., Walley, A. J., and Froguel, P. (2005) The genetics of human obesity. Nat. Rev. Genet. 6, 221-234.
6. Mathes, W. F., Kelly, S. A., and Pomp, D. (2011) Advances in comparative genetics: influence of genetics on obesity. Br. J. Nutr. 106 Suppl 1, S1-S10.
7. Low, S., Chin, M. C., and Deurenberg-Yap, M. (2009) Review on epidemic of obesity. Ann. Acad. Med. Singapore 38, 57-59.
8. Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., et al. (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377, 557-567.
9. Kelly, T., Yang, W., Chen, C. S., Reynolds, K., and He, J. (2008) Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. 32, 1431-1437.
10. Blumentals, W. A., Hwu, P., Kobayashi, N., and Ogura, E. (2013) Obesity in hospitalized type 2 diabetes patients: a descriptive study. Med. Sci. Monit. 19, 359-365.
11. Hall, J. E. (2003) The kidney, hypertension, and obesity. Hypertension 41, 625-633.
12. Roberts, C. K., Hevener, A. L., and Barnard, R. J. (2013) Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comp. Physiol. 3, 1-58.
13. De Pergola, G., and Silvestris, F. (2013) Obesity as a major risk factor for cancer. J. Obes. 2013, 291546. doi: 10.1155/2013/291546.
14. Kalra, E. K. (2003) Nutraceutical-definition and introduction. AAPS Pharm. Sci. 5, E25.
15. Pandey, N., Meena, R. P., Rai, S.K., and Pandey-Rai, S. (2011) Medicinal plants derived nutraceuticals: A re-emerging health aid. Int. J. Pharma Bio Sci. 2, 419-441.
16. Martirosyan, D. M. ed. (2011) Functional Foods and Chronic Diseases: Science and Practice, Vol. 8. Food Science Publisher, Richardson, TX, USA.
17. Rajat, S., Manisha, S., Robin, S., and Sun, K. (2012) Nutraceuticals: a review. Int. Res. J. Pharm. 3, 95-99.
18. Brower, V. (1998) Nutraceuticals: poised for a healthy slice of the healthcare market? Nat. Biotechnol. 16, 728-731.
19. National Research Council. (2005) Dietary Supplements: A Framework for Evaluating Safety. The National Academies Press, Washington, DC.
20. Zeisel, S. H. (1999) Regulation of "nutraceuticals". Science 285, 1853-1855.
21. Chaput, J. P., St-Pierre, S., and Tremblay, A. (2007) Currently available drugs for the treatment of obesity: sibutramine and orlistat. Mini Rev. Med. Chem. 7, 3-10.
22. Wilding, J. P. (2007) Treatment strategies for obesity. Obes. Rev. 8 Suppl 1, 137-144.
23. Mayer, M. A., Höcht, C., Puyó, A., and Taira, C. A. (2009) Recent advances in obesity pharmacotherapy. Curr. Clin. Pharmacol. 4, 53-61.
24. Nakayama, T., Suzuki, S., Kudo, H., Sassa, S., Nomura, M., and Sakamoto, S. (2007) Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet. J. Ethnopharmacol. 109, 236-240.
25. Park, M. Y., Lee, K. S., and Sung, M. K. (2005) Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPARgamma, and LPL mRNA expressions. Life Sci. 77, 3344-3354.
26. Rayalam, S., Della-Fera, M. A., and Baile, C. A. (2008) Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem. 19, 717-726.
27. Yun, J. W. (2010) Possible anti-obesity therapeutics from nature-a review. Phytochemistry 71, 1625-1641.
28. Rosen, E. D., and Spiegelman, B. M. (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853.
29. Rosen, E. D. and Spiegelman, B. M. (2014) What we talk about when we talk about fat. Cell 156, 20-44.
30. Virtue, S. and Vidal-Puig, A. (2008) It's not how fat you are, it's what you do with it that counts. PLoS Biol. 6, e237.
31. Nichols, G. A. and Gomez-Caminero, A. (2007) Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes. Metab. 9, 96-102.
32. Naukkarinen, J., Heinonen, S., Hakkarainen, A., Lundbom, J., Vuolteenaho, K., et al. (2014) Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia 57, 167-176.
33. Colitti, M. (2012) New insights in adipose tissue biology: from obesity to therapeutic prospects. Endocrinol. Metabol. Syndr. 1, e103.
34. Wells, H. (1940) Adipose tissue, a neglected subject. JAMA 114, 2177-2183.
35. Cinti, S. (1999) The adipose organ. In Nutrition and Health: Adipose Tissue and Adipokines in Health and Disease. (Fantuzzi, G., and Mazzone, T., eds.) pp. 3-19, © Humana Press, Totowa, NJ.
36. Cinti, S. (2005) The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids 73, 9-15.
37. Cinti, S. (2012) The adipose organ at a glance. Dis. Model Mech. 5, 588-594.
38. Cannon, B, and Nedergaard, J. (2004) Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359.
39. Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., et al. (2009) Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525.
40. Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., et al. (2009) Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517.
41. van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M., Kemerink, G. J., et al. (2009) Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508.
42. Petrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., et al. (2010) Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 285, 7153-7164.
43. Frontini, A. and Cinti, S. (2010) Distribution and development of brown adipocytes in the murine and human adipose organ. Cell. Metab.11, 253-256.
44. Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., et al. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376.
45. Fischer-Posovszky, P., Wabitsch, M., and Hochberg, Z. (2007) Endocrinology of adipose tissue-an update. Horm. Metab. Res. 39, 314-321.
46. Granneman, J. G., Li, P., Zhu, Z., and Lu, Y. (2005) Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 289, E608-E616.
47. Murano, I., Barbatelli, G., Giordano, A., and Cinti, S. (2009) Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J. Anat. 214, 171-178.
48. Rosenwald, M., Perdikari, A., Rülicke, T., and Wolfrum, C. (2013) Bi-directional interconversion of brite and white adipocytes. Nat. Cell Biol. 15, 659-667.
49. Wang, Q. A., Tao, C., Gupta, R. K., and Scherer, P. E. (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19, 1338-1344.
50. Morroni, M., Giordano, A., Zingaretti, M. C., Boiani, R., De Matteis, R., et al. (2004) Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland. PNAS 101, 16801-16806.
51. Symonds, M. E., ed. (2012) Adipose Tissue Biology. Springer, New York.
52. Henry, S. L., Bensley, J. G., Wood-Bradley, R. J., Cullen-McEwen, L. A., Bertram, J. F., et al. (2012) White adipocytes: more than just fat depots. Int. J. Biochem. Cell Biol. 44, 435-440.
53. Large, V., Peroni, O., Letexier, D., Ray, H., and Beylot, M. (2004) Metabolism of lipids in human white adipocyte. Diabetes Metab. 30, 294-309.
54. Green, H. and Kehinde, O. (1975) An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5, 19-27.
55. Moreno-Navarrete, J. M. and Fernández-Real, J. M. (2012) Adipocyte differentiation. In Adipose Tissue Biology. (Symonds, M. E., ed.) pp. 17-38, Springer, London, UK.
56. Fève, B. (2005) Adipogenesis: cellular and molecular aspects. Best Pract. Res. Clin. Endocrinol. Metab. 19, 483-499.
57. Tang, Q. and Lane, M. (2012) Adipogenesis: from stem cell to adipocyte. Ann. Rev. Biochem. 81, 715-736.
58. MacDougald, O. A. and Lane, M. D. (1995) Transcriptional regulation of gene expression during adipocyte differentiation. Ann. Rev. Biochem. 64, 345-373.
59. Morrison, R. F. and Farmer, S. R. (2000) Hormonal signaling and transcriptional control of adipocyte differentiation. J. Nutr. 130, 3116S-3121S.
60. Ntambi, J. M. and Young-Cheul, K. (2000) Adipocyte differentiation and gene expression. J. Nutr. 130, 3122S-3126S.
61. Wu, Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., et al. (1999) Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151-158.
62. Nakachi, Y., Yagi, K., Nikaido, I., Bono, H., Tonouchi, M., et al. (2008) Identification of novel PPARgamma target genes by integrated analysis of ChIP-on-chip and microarray expression data during adipocyte differentiation. Biochem. Biophys. Res. Commun. 372, 362-366.
63. Kim, J. B., Wright, H. M., Wright, M., and Spiegelman, B. M. (1998) ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 95, 4333-4337.
64. Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M. (2000) Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293-1307.
65. Ericsson, J., Jackson, S. M., Kim, J. B., Spiegelman, B. M., and Edwards, P. A. (1997) Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element binding protein-responsive gene. J. Biol. Chem. 272, 7298-7305.
66. Koppen, A. and Kalkhoven, E. (2010) Brown vs white adipocytes: the PPARγ coregulator story. FEBS Lett. 584, 3250-3259.
67. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., et al. (1995) Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci. USA 92, 7921-7925.
68. Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., and Camp, H. S. (2002) PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev. 16, 27-32.
69. Dali-Youcef, N., Lagouge, M., Froelich, S., Koehl, C., Schoonjans, K., et al. (2007) Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann. Med. 39, 335-345.
70. Yang, T., Fu, M., Pestell, R., and Sauve, A. A. (2006) SIRT1 and endocrine signaling. Trends Endocrinol. Metab. 17, 186-191.
71. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
72. Tong, Q., Dalgin, G., Xu, H., Ting, C. N., Leiden, J. M., et al. (2000) Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290, 134-138.
73. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262.
74. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., et al. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277, 32571-32577.
75. Mulligan, J. D., Gonzalez, A. A., Stewart, A. M., Carey, H. V., and Saupe, K. W. (2007) Upregulation of AMPK during cold exposure occurs via distinct mechanisms in brown and white adipose tissue of the mouse. J. Physiol. 580, 677-684.
76. Bauwens, J. D., Schmuck, E. G., Lindholm, C. R., Ertel, R. L., Mulligan, J. D., et al. (2011) Cold tolerance, cold- induced hyperphagia, and nonshivering thermogenesis are normal in alpha(1)-AMPK-/- mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R473-R483.
77. Habinowski, S. A. and Witters, L. A. (2001) The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 286, 852-856.
78. Gregoire, F. M. (2001) Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. 226, 997-1002.
79. Lee, H., Kang, R., Bae, S., and Yoon, Y. (2011) AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/beta-catenin pathway in 3T3-L1 adipocytes. Int. J. Mol. Med. 28, 65-71.
80. Wu, Z. and Wang, S. (2013) Role of Kruppel-like transcription factors in adipogenesis. Dev. Biol. 373, 235-243.
81. McConnell, B. B. and Yang, V. W. (2010) Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90, 1337-1381.
82. Sue, N., Jack, B. H., Eaton, S. A., Pearson, R. C., Funnell, A. P., et al. (2008) Targeted disruption of the basic Kruppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol. Cell Biol. 28, 3967-3978.
83. Birsoy, K., Chen, Z., and Friedman, J. (2008) Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 7, 339-347.
84. Oishi, Y., Manabe, I., Tobe, K., Tsushima, K., Shindo, T., et al. (2005) Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1, 27-39.
85. Li, D., Yea, S., Li, S., Chen, Z., Narla, G., et al. (2005) Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J. Biol. Chem. 280, 26941-26952.
86. Pei, H., Yao, Y., Yang, Y., Liao, K., and Wu, J. R. (2011) Kruppel-like factor KLF9 regulates PPARg transactivation at the middle stage of adipogenesis. Cell Death Differ. 18, 315-327.
87. Mori, T., Sakaue, H., Iguchi, H., Gomi, H., Okada, Y., et al. (2005) Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 280, 12867-12875.
88. Wang, Y., Kim, K. A., Kim, J. H., and Sul, H. S. (2006) Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J. Nutr. 136, 2953-2956.
89. Harp, J. B. (2004) New insights into inhibitors of adipogenesis. Curr. Opin. Lipidol. 15, 303-307.
90. Sul, H.S. (2009) Minireview: pref-1: role in adipogenesis and mesenchymal cell fate. Mol. Endocrinol. 23, 1717-1725.
91. Harms, M., and Seale, P. (2013) Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263.
92. Nakagami, H. (2013) The mechanism of white and brown adipocyte differentiation. Diabetes Metab. J. 37, 85-90.
93. Cao, W., Medvedev, A. V., Daniel, K. W., and Collins, S. (2001) beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J. Biol. Chem. 276, 27077-27082.
94. Lindgren, E. M., Nielsen, R., Petrovic, N., Jacobsson, A., Mandrup, S., et al. (2004) Noradrenaline represses PPAR (peroxisome-proliferator-activated receptor) gamma2 gene expression in brown adipocytes: intracellular signalling and effects on PPARgamma2 and PPARgamma1 protein levels. Biochem. J. 382 Pt 2, 597-606.
95. Giralt, M., and Villarroya, F. (2013) White, brown, beige/brite: different adipose cells for different functions? Endocrinology 154, 2992-3000.
96. Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., et al. (2007) Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6, 38-54.
97. Seale, P., Kajimura, S., and Spiegelman, B. M. (2009) Transcriptional control of brown adipocyte development and physiological function--of mice and men. Genes Dev. 23, 788-797.
98. Seale, P. (2010) Transcriptional control of brown adipocyte development and thermogenesis. Int. J. Obes. 34 Suppl 1, S17-S22.
99. Chartoumpekis, D. V., Habeos, I. G., Ziros, P. G., Psyrogiannis, A. I., Kyriazopoulou, V. E., et al. (2011) Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol. Med. 17, 736-740.
100. Li, P., Zhu, Z., Lu, Y., and Granneman, J. G. (2005) Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha. Am. J. Physiol. Endocrinol. Metab. 289, E617-E626.
101. Suárez, J., Rivera, P., Arrabal, S., Crespillo, A., Serrano, A., et al. (2013) Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis. Model. Mech. 7, 129-141.
102. Sell, H., Deshaies, Y., and Richard, D. (2004) The brown adipocyte: update on its metabolic role. Int. J. Biochem. Cell Biol. 36, 2098-2104.
103. Barbatelli, G., Murano, I., Madsen, L., Hao, Q., Jimenez, M., et al. (2010) The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298, E1244-E1253.
104. Wang, Q. A., Tao, C., Gupta, R. K., and Scherer, P. E. (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19, 1338-1344.
105. Qian, S. W., Tang, Y., Li, X., Liu, Y., Zhang, Y. Y., et al. (2013) BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc. Natl. Acad. Sci. USA 110, E798-E807.
106. Wu, J., Cohen, P., and Spiegelman, B. M. (2013) Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 2, 234-250.
107. Ishibashi, J. and Seale, P. (2010) Medicine. Beige can be slimming. Science 328, 1113-1114.
108. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., et al. (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150, 620-632.
109. Sawada, T., Miyoshi, H., Shimada, K., Suzuki, A., Okamatsu-Ogura, Y., et al. (2010) Perilipin overexpression in white adipose tissue induces a brown fat-like phenotype. PLoS One 5, e14006.
110. Xie, H., Lim, B., and Lodish, H. F. (2009) MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58, 1050-1057.
111. McGregor, R. A., and Choi, M. S. (2011) microRNAs in the regulation of adipogenesis and obesity. Curr. Mol. Med. 11, 304-316.
112. Lin, Q., Gao, Z., Alarcon, R. M., Ye, J., and Yun, Z. (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J. 276, 2348-2358.
113. Kim, S. Y., Kim, A. Y., Lee, H. W., Son, Y. H., Lee, G. Y., et al. (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem. Biophys. Res. Commun. 392, 323-328.
114. Kinoshita, M., Ono, K., Horie, T., Nagao, K., Nishi, H., et al. (2010) Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol. Endocrinol. 24, 1978-1987.
115. Trajkovski, M. and Lodish, H. (2013) MicroRNA networks regulate development of brown adipocytes. Trends Endocrinol. Metab. 24, 442-450.
116. Zhang, R., Wang, D., Xia, Z., Chen, C., Cheng, P., et al. (2013) The role of microRNAs in adipocyte differentiation. Front. Med. 7, 223-230.
117. Wichtl, M., ed. (2004) Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd ed. Medpharm CRC Press, GmbH Scientific Publisher, Stuttgart, Germany.
118. Stohs, S. J., Preuss, H. G., and Shara, M. (2011) The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytother. Res. 25, 1421-1428.
119. Fugh-Berman, A. and Myers, A. (2004) Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp. Biol. Med. (Maywood) 229, 698-704.
120. Carpéné, C., Galitzky, J., Fontana, E., Atgié, C., Lafontan, M., et al. (1999) Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch. Pharmacol. 359, 310-321.
121. Mercader, J., Wanecq, E., Chen, J., and Carpéné, C. (2011) Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium. J. Physiol. Biochem. 67, 443-452.
122. Kim, G. S., Park, H. J., Woo, J. H., Kim, M. K., Koh, P. O., et al. (2012) Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Complement Altern. Med. 12, 31.
123. Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H. III, Arden, K. C., et al. (2003) The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119-129.
124. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
125. Kang, S. I., Shin, H. S., Ko, H. C., and Kim, S. J. (2013) Effects of sinensetin on lipid metabolism in mature 3T3-L1 adipocytes. Phytother. Res. 27, 131-134.
126. Kanda, K., Nishi, K., Kadota, A., Nishimoto, S., Liu, M. C., et al. (2012) Nobiletin suppresses adipocyte differentiation of 3T3-L1 cells by an insulin and IBMX mixture induction. Biochim. Biophys. Acta 1820, 461-468.
127. Wesolowska, O., Wiśniewski, J., Sroda-Pomianek, K., Bielawska-Pohl, A., Paprocka, M., et al. (2012) Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants. J. Nat. Prod. 75, 1896-1902.
128. Arul, D. and Subramanian, P. (2013) Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol. Oncol. Res. 19, 763-770.
129. Morgan, M. and Bone, K. (2005) Rhodiola rosea-Rhodiola. MediHerb. Newslett. 47, 1-4.
130. Panossian, A., Wikman, G., and Sarris, J. (2010) Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 17, 481-493.
131. Kur'yanov, A. A., Bondarenko, L. T., Kurkin, V. A., Zapesochnaya, G. G., Dubichev, A. A., et al. (1991) Determination of the biologically active components of the rhizomes of Rhodiola rosea. Chem. Nat. Comp. 27, 276-279.
132. Verpeut, J. L. Walters, A. L., and Bello, N. T. (2013) Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity. Nutr. Res. 33, 503-512.
133. Zhang, B. C., Li, W. M., Guo, R., and Xu, Y. W. (2012) Salidroside decreases atherosclerotic plaque formation in low density lipoprotein receptor-deficient mice. Evid. Based Complement. Alternat. Med. 2012, 607508.
134. Wang, S. H., Wang, W. J., Wang, X. F., and Chen, W. H. (2004) Effects of salidroside on carbohydrate metabolism and differentiation of 3T3-L1 adipocytes. Zhong Xi Yi Jie He Xue Bao 2, 193-195.
135. Cheng, Y. Z., Chen, L. J., Lee, W. J., Chen, M. F., Jung Lin, H., et al. (2012) Increase of myocardial performance by Rhodiola-ethanol extract in diabetic rats. J. Ethnopharmacol. 144, 234-239.
136. Mottillo, E. P., Bloch, A. E., Leff, T., and Granneman, J. G. (2012) Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ in brown adipocytes to match fatty acid oxidation with supply. J. Biol. Chem. 287, 25038-25048.
137. Wang, Y. X., Lee, C. H., Tiep, S., Yu, R. T., Ham, J., et al. (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113, 159-170.
138. Barish, G. D., Narkar, V. A., and Evans, R. M. (2006) PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116, 590-597.
139. Lee, O. H., Kwon, Y. I., Apostolidis, E., Shetty, K., and Kim, Y. C. (2011) Rhodiola-induced inhibition of adipogenesis involves antioxidant enzyme response associated with pentose phosphate pathway. Phytother. Res. 25, 106-115.
140. Takahashi, T., Tabuchi, T., Tamaki, Y., Kosaka, K., Takikawa, Y., et al. (2009) Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem. Biophys. Res. Commun. 382, 549-554.
141. Ninomiya, K., Matsuda, H., Shimoda, H., Nishida, N., Kasajima, N., et al. (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg. Med. Chem. Lett. 14, 1943-1946.
142. Gaya, M., Repetto, V., Toneatto, J., Anesini, C., Piwien-Pilipuk, G., et al. (2013) Antiadipogenic effect of carnosic acid, a natural compound present in Rosmarinus officinalis, is exerted through the C/EBPs and PPARγ pathways at the onset of the differentiation program. Biochim. Biophys. Acta 1830, 3796-3806.
143. Raina, K., and Agarwal, R. (2007) Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms. Acta Pharmacol. Sin. 28, 1466-1475.
144. Zhan, T., Digel, M., Küch, E. M., Stremmel, W., and Füllekrug, J. (2011) Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins. J. Cell. Biochem. 112, 849-859.
145. Ka, S. O., Kim, K. A., Kwon, K. B., Park, J. W., and Park, B. H. (2009) Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int. J. Mol. Med. 23, 633-637.
146. Goldstein, J. L., DeBose-Boyd, R. A., and Brown, M. S. (2006) Protein sensors for membrane sterols. Cell 124, 35-46.
147. Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., et al. (2002) Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489-500.
148. Li, J., Takaishi, K., Cook, W., McCorkle, S. K., and Unger, R. H. (2003) Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc. Natl. Acad. Sci. USA 100, 9476-9481.
149. Schütz, K., Carle, R., and Schieber, A. (2006) Taraxacum-a review on its phytochemical and pharmacological profile. J. Ethnopharmacol. 107, 313-323.
150. Davaatseren, M., Hur, H. J., Yang, H. J., Hwang, J. T., Park, J. H., et al. (2013) Taraxacum official (Dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food Chem. Toxicol. 58, 30-36.
151. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174.
152. Foretz, M., Ancellin, N., Andreelli, F., Saintillan, Y., Grondin, P., et al. (2005) Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54, 1331-1339.
153. Ovadje, P., Chochkeh, M., Akbari-Asl, P., Hamm, C., and Pandey, S. (2012) Selective induction of apoptosis and autophagy through treatment with dandelion root extract in human pancreatic cancer cells. Pancreas 41, 1039-1047.
154. Ovadje, P., Chatterjee, S., Griffin, C., Tran, C., Hamm, C., et al. (2011) Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J. Ethnopharmacol. 133, 86-91.
155. González-Castejón, M., García-Carrasco, B., Fernández-Dacosta, R., Dávalos, A., and Rodriguez-Casado, A. Reduction of adipogenesis and lipid accumulation by Taraxacum officinale (dandelion) extracts in 3T3L1 adipocytes: an in vitro study. Phytother. Res., in press. doi: 10.1002/ptr.5059.
156. Herman, A., and Herman, A. P. (2012) Caffeine's mechanisms of action and its cosmetic use. Skin Pharmacol. Physiol. 26, 8-14.
157. Murosaki, S., Lee, T. R., Muroyama, K., Shin, E. S., Cho, S. Y., et al. (2007) A combination of caffeine, arginine, soy isoflavones, and Lcarnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J. Nutr. 137, 2252-2257.
158. Shimoda, H., Seki, E., and Aitani, M. (2006) Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern. Med. 6, 9.
159. Han, L. K., Takaku, T., Li, J., Kimura, Y., and Okuda, H. (1999) Anti-obesity action of oolong tea. Int. J. Obes. Relat. Metab. Disord. 23, 98-105.
160. Fredholm, B. B., and Lindgren, E. (1984) The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. Acta Pharmacol. Toxicol. 54, 64-71.
161. Nakabayashi, H., Hashimoto, T., Ashida, H., Nishiumi, S., and Kanazawa, K. (2008) Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. Biofactors 34, 293-302.
162. Matsuoka, S., Moriyama, T., Ohara, N., Tanimura, K., and Maruo, T. (2006) Caffeine induces apoptosis of human umbilical vein endothelial cells through the caspase-9 pathway. Gynecol. Endocrinol. 22, 48-53.
163. Bode, A. M. and Dong, Z. (2007) The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett. 247, 26-39.
164. Su, S. H., Shyu, H. W., Yeh, Y. T., Chen, K. M., Yeh, H., et al. (2013) Caffeine inhibits adipogenic differentiation of primary adipose-derived stem cells and bone marrow stromal cells. Toxicol. In Vitro 27, 1830-1837.
165. Su, S. J. Chang, K. L., Su, S. H., Yeh, Y. T., Shyu, H. W., et al. (2013) Caffeine regulates osteogenic differentiation and mineralization of primary adipose derived stem cells and a bone marrow stromal cell line. Int. J. Food Sci. Nutr. 64, 429-436.
166. Witkin, J. M., and Li, X. (2013) Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy. CNS Neurol. Disord. Drug Targets 12, 487-497.
167. Ejaz, A., Wu, D., Kwan, P., and Meydani, M. (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 139, 919-925.
168. Zhao, J., Sun, X. B., Ye, F., and Tian, W. X. (2011) Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol. Cell Biochem. 35, 19-28.
169. Kim, C. Y., Le, T. T., Chen, C., Cheng, J. X., and Kim, K. H. (2011) Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 22, 910-920.
170. Lee, Y. K., Lee, W. S., Hwang, J. T., Kwon, D. Y., Surh, Y. J., et al. (2009) Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food Chem. 57, 305-310.
171. Green, A., Krause, J., and Rumberger, J. M. (2013) Curcumin is a direct inhibitor of glucose transport in adipocytes. Phytomedicine 21, 118-122.
172. Asai, A. and Miyazawa, T. (2001) Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J. Nutr. 131, 2932-2935.
173. Madsen, L., Petersen, R. K., and Kristiansen, K. (2005) Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim. Biophys. Acta 1740, 266-286.
174. Okuno, M., Kajiwara, K., Imai, S., Kobayashi, T., Honma, N., et al. (1997) Perilla oil prevents the excessive growth of visceral adipose tissue in rats by down-regulating adipocyte differentiation. J. Nutr. 127, 1752-1757.
175. Wortman, P., Miyazaki, Y., Kalupahana, N. S., Kim, S., Hansen-Petrik, M., et al. (2009) n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes. Nutr. Metab. (London) 6, 5-16.
176. Kim, H. K., Della-Fera, M., Lin, J., and Baile, C. A. (2006) Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J. Nutr. 136, 2965-2969.
177. Flachs, P., Horakova, O., Brauner, P., Rossmeisl, M., Pecina, P., et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48, 2365-2375.
178. Bremer, J. and Norum, K. R. (1982) Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. J. Lipid Res. 23, 243-56.
179. Barber, E., Sinclair, A. J., and Cameron-Smith, D. (2013) Comparative actions of omega-3 fatty acids on in-vitro lipid droplet formation. Prostaglandins Leukot. Essent. Fatty Acids 89, 359-366.
180. Yang, B. L., Heckmann, B. L., Zhang, X, Smas, C. M., and Liu, J. (2013) Distinct mechanisms regulate ATGL-mediated adipocyte lipolysis by lipid droplet coat proteins. Mol. Endocrinol. 27, 116-126.
181. Buckley, J. D., and Howe, P. R. (2010) Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2, 1212-1230.
182. Warnke, I., Goralczyk, R., Fuhrer, E., and Schwager, J. (2011) Dietary constituents reduce lipid accumulation in murine C3H10 T1/2 adipocytes: a novel fluorescent method to quantify fat droplets. Nutr. Metab. 8, 30-43.
183. Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F., and Deckelbaum, R. J. (1998) Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273, 25537-25540.
184. Robinson, B. S., Hii, C. S., Poulos, A., and Ferrante, A. (1997) Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91, 274-280.
185. Andersen, C., Rayalam, S., Della-Fera, M. A., and Baile, C. A. (2010) Phytochemicals and adipogenesis. Biofactors 36, 415-422.
186. Vigilanza, P., Aquilano, K., Baldelli, S., Rotilio, G., and Ciriolo, M. R. (2011) Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. J. Cell. Physiol. 22, 2016-2024.
187. Chen, S., Li, Z., Li, W., Shan, Z., and Zhu, W. (2011) Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK. Can. J. Physiol. Pharmacol. 89, 793-799.
188. Hwang, J. T., Kim, S., and Choi, S. Y. (2010) Inhibitory effect of (E)-1, 2-di (3, 5-dimethoxyphenyl) ethene on 3T3-L1 adiopocyte differentiation. Pharmazie 65, 903-905.
189. Rayalam, S., Yang, J. Y., Ambati S, Della-Fera, M. A., and Baile, C. A. (2008) Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 22, 1367-1371.
190. Chen, S., Xiao, X., Feng, X., Li, W., Zhou, N., et al. (2012) Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J. Nutr. Biochem. 23, 1100-1112.
191. Mader, I., Wabitsch, M., Debatin, K. M., Fischer-Posovszky, P., et al. (2010) Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis. FASEB J. 24, 1997-2009.
192. Jin, Q., Yan, T., Ge, X., Sun, C., Shi, X., et al. (2007) Cytoplasm-localized SIRT1 enhances apoptosis. J. Cell Physiol. 213, 88-97.
193. Yi, J., and Luo, J. (2010) SIRT1 and p53, effect on cancer, senescence and beyond. Biochim. Biophys. Acta 1804, 1684-1689.
194. Zhang, X. H., Huang, B., Choi, S. K., and Seo, J. S. (2012) Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation. Nutr. Res. Pract. 6, 286-293.
195. Kwon, J. Y., Seo, S. G., Yue, S., Cheng, J. X., Lee, K. W., et al. (2012) An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis. Nutr. Res. 32, 607-616.
196. Mitterberger, M. C. and Zwerschke, W. (2013) Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1356-1376.
197. Konings, E., Timmers, S., Boekschoten, M. V., Goossens, G. H., Jocken, J. W., et al. (2013) The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. Int. J. Obes. 38, 470-473.
198. Arunakumara, K., and Subasinghe, S. (2010) Salacia reticulata wight: a review of botany, phytochemistry and pharmacology. Tropical Agric. Res. Ext. 13, 41-47.
199. Yoshikawa, M., Shimoda, H., Nishida, N., Takada, M., and Matsuda, H. (2002) Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J. Nutr. 132, 1819-1824.
200. Shimada, T., Nagai, E., Harasawa, Y., Watanabe, M., Negishi, K., et al. (2011) Salacia reticulata inhibits differentiation of 3T3-L1 adipocytes. J. Ethnopharmacol. 136, 67-74.
201. Liu, L., Yang, M., Lin, X., Li, Y., Liu, C., et al. (2013) Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats. J. Ethnopharmacol. 150, 1045-1052.
202. Dulloo, A. G. (2011) The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Obes. Rev. 12, 866-883.
203. Miyashita, K., Nishikawa, S., Beppu, F., Tsukui, T., Abe, M., et al. (2011) The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J. Sci. Food Agric. 91, 1166-1174.
204. Maeda, H., Hosokawa, M., Sashima, T., Takahashi, N., Kawada, T., et al. (2006) Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int. J. Mol. Med. 18, 147-152.
205. Yim, M. J., Hosokawa, M., Mizushina, Y., Yoshida, H., Saito, Y., et al. (2011) Suppressive effects of Amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPARγ and C/EBPα mRNA expression. J. Agric. Food Chem. 59, 1646-1652.
206. Lai, C. S., Tsai, M. L., Badmaev, V., Jimenez, M., Ho, C. T., et al. (2012) Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARγ and C/EBPs and modulation of SIRT-1, AMPK, and FoxO pathways. J. Agric. Food Chem. 60, 1094-1101.
207. Kang, S. I., Ko, H. C., Shin, H. S., Kim, H. M., Hong, Y. S., et al. (2011) Fucoxanthin exerts differing effects on 3T3-L1 cells according to differentiation stage and inhibits glucose uptake in mature adipocytes. Biochem. Biophys. Res. Commun. 409, 769-774.
208. Bonet, M. L., Oliver, P., and Palou, A. (2013) Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim. Biophys. Acta 831, 969-985.
209. Maeda, H., Hosokawa, M., Sashima, T., Funayama, K., and Miyashita, K. (2005) Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun. 332, 392-397.
210. Maeda, H., Hosokawa, M., Sashima, T., Murakami-Funayama, K., et al. (2009) Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep. 2, 897-902.
211. Rodríguez, V. M., Portillo, M. P., Picó, C., Macarulla, M. T., et al. (2002) Olive oil feeding up-regulates uncoupling protein genes in rat brown adipose tissue and skeletal muscle. Am. J. Clin. Nutr. 75, 213-220.
212. Oi-Kano, Y., Kawada, T., Watanabe, T., Koyama, F., Watanabe, K., et al. (2008) Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J. Nutr. Sci. Vitaminol. 54, 363-370.
213. Vögler, O., López-Bellan, A., Alemany, R., Tofé, S., González, M., et al. (2008) Structure-effect relation of C18 long-chain fatty acids in the reduction of body weight in rats. Int. J. Obes. (London). 32, 464-473.
214. Mercader, J., Palou, A., and Bonet, M. L. (2011) Resveratrol enhances fatty acid oxidation capacity and reduces resistin and retinol-binding protein 4 expression in white adipocytes. J. Nutr. Biochem. 22, 828-834.
215. Janovská, P., Flachs, P., Kazdová, L., and Kopecký, J. (2013) Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. Physiol. Res. 62, 153-161.
216. Flachs, P., Rossmeisl, M., Kuda, O., and Kopecky, J. (2013) Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. Biochim. Biophys. Acta 1831, 986-1003.
217. Siriwardhana, N., Kalupahana, N. S., Cekanova, M., LeMieux, M., Greer, B., et al. (2013) Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 24, 613-623.